BioPortfolio Bulletin

  http://www.bioportfolio.co.uk/bulletin_62.htm              February 8th 2005

• 1,000's Life Science Jobs - launch of RSS feed & 3:1 offer
• Management Reports - new publishers, new reports
• Directories - identify your customers!
• Life Science Conference database - over 150 events listed
• BioWatch News Tracking - the "eyes and the ears" of the life science industry - $8.50 per month - First month FREE
• 500 News Health Subjects/Indications
• CANTAB Cambridge Neuropsychological Test Automated Battery
• Advertising and sponsorship opportunities
• Search tools - evaluate BioNews and BioWeb

• Register your Free Employer Account.
• Post Scientific Jobs to ALL BioJobNetwork Partner Sites.
• Cost $100USD per Standard Listing, $125USD per Premium Listing.
• All postings active for 60 days.
• Receive Resumes via E-mail.
• Featured Banners Available.

• Career Center
• Register for Job Agent
• Search

New User? Register here to apply online or create a personal Bio Job Agent with your resume/CV and be notified, daily, of new postings - Register now!

• Create up to 3 Resumes or CVs on a single account.
• Apply to a Job with just One Click.
• Register a personal Bio Job Agent for New Job Notices.
• Manage your Privacy with our Privacy Tools.
• Elect to have your Resume Searched.
• Access your account from ANY BioJobNetwork Partner Site.
• Review our strict Privacy Policies.

View RSS BioVacancy Job Search

Table of Contents

RSV Mab, rDNA (Synagis from MedImmune)
EPO rDNA Amgen
FDA Approvals

Buy: BIOPHARMA: Biopharmaceutical Products in the U.S. Market 3rd Edition

Click to order: Biopharmaceutical Products in the U.S. Market
 

Late Stage Deals - Strategy, Structure and Payment Terms
Dealmaking in the pharmaceutical and biotechnological industries covers a wide variety of agreements between individuals, companies and institutions from simple late-stage product acquisitions (deals relating to products in clinical development, approval, launch and marketing) through to complex discovery and target research and development deals.

Strategies for Biogeneric Success
What will determine success?
Development of biogeneric molecules for sale in the potentially highly lucrative US and Western European markets depends on the ability to answer three key questions

Early Stage and Discovery Deals - Strategy, Structure and Payment Terms
Early stage partnering is a core component of both biotech and pharmaceutical business strategy, allowing access to promising new and emerging technologies, even though the risk of compound failure is high.

Intellectual property strategies for pharmaceutical development
This report provides an introduction to the intellectual property strategies involved in the development of pharmaceuticals from the discovery of an NCE, through to its launch, with details and advice on the appropriate decisions and actions. The report also deals with the different types of inventions that may occur.

The Global Ophthalmic Pharmaceutical Market 2004-2009
Driven by demographic trends, such as an increasing aged population, the global ophthalmic pharmaceutical market is set to become a serious growth area experiencing a compound annual growth rate of 13.0% to 2009.

Orphan Drugs: Future Directions for a High Growth Market 2004-2009
In 1983 there were just 10 orphan drugs available to treat rare diseases, but in the space of 20 years there are now 210 different drugs resulting in a market that is worth more than $27 billion today.

European Hospital register
Detailed information about hospitals in 20 European countries plus a updated CD ROM every 3 months. CD ROM database plus search engine 
View pdf brochure

American Hospital Register
A detailed database of 5,871 hospitals in the United States. The AHR user has the same detailed format as the European Hospital Register.

US Hospital Register

• Search Events
   
• Post Events

From cancer research to patient care, plant sciences to GM crops - you will find the events listed on BioPortfolioEvents.  Users are free to search the database and event organisers can post events for a nominal charge.

This unique service pulls together thousands of biotechnology, pharmaceutical and healthcare press releases and news items from around the globe.  The BioWatch News Agent service will keep you "up-to-speed" on breaking news and opinions. 

• Platinum membership is just $8.50 per month - FIRST MONTH IS FREE! - subscribe here!
• Silver membership starts at $50.00 per year per Group Agent - subscribe here!
• Gold Membership starts at $95.00 per year per Personal Agent - subscribe here!

Some handy uses of our service include:

• monitoring a developing news story
• keeping current on competitors or products
• getting the latest on R&D and clinical trials for a human condition eg obesity, cancer
• keeping tabs on agreements, deals, patents etc...more!

http://www.bioportfolio.com/news_tracking/index.htm

BioPortfolio have published 500 dynamic web pages that change every 30 minutes 24/7/365!  As news items are stored on our proprietary BioNews Search Engine you can view the results online.  A-Z of 500 health conditions - click alphabet for listing:

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

• Cancers (28)
• AIDS and STDs (8)
• Bones (12)
• Brain and Nervous System (29)
• Cardiovascular Heart and Blood (22)
• Diabetes (3)
• Digestive System and Obesity (14)
• Infectious Diseases (11)
• Pain (7)
• Prenatal and Child Health (12)
• Respiration and Lungs (10)
• Senses (Ear, Nose, Throat, Eye and Vision) (10)
• Sexual Health (13)
• Skin (12)

CANTAB is used in over 400 universities and institutions, in 34 countries, and is cited in over 200 publications which are listed in our bibliography. In development for over 15 years, it has a well standardised and validated, large normative database.

Whatever your cognitive assessment needs, in academic research or clinical trials, CANTAB can provide a solution.

CANTAB benefits
CANTAB detects early cognitive changes in many CNS disorders such as Alzheimer’s disease, Parkinson’s disease, schizophrenia and depression.
• Touch screen technology for rapid and non-invasive cognitive assessment
• Language-independent tests are ideal for multinational studies and testing very young, disturbed or dementing subjects
• Exports results data into spreadsheets and statistical analysis packages
• Suitable for repeat testing
• Well validated
• Easy to use

Interested? - go to http://www.bioportfolio.com/cantab/Default.htm

Need feedback? - go to http://www.bioportfolio.com/cantab/request.htm

BioPortfolio Limited is a leading provider of business information, products and services to the biotechnology, pharmaceutical and life science sectors. The company serves millions of users with information to help generate a greater understanding of who, what, where and why biotechnology will impact on our lives.

BioPortfolio’s position as a leading life science site is confirmed by the site’s traffic ranking on www.Alexa.com.  BioPortfolio are ranked higher than the US Bio Industry Organization, BioOnline and is ranked second overall in the life science / biotechnology space after BioSpace.

BioPortfolio.com offers flexible, cost effective and highly targeted advertising to the bio/pharma sectors, executives, researchers and healthcare professional. Using BioPortfolio you can:

• build your company/brand awareness

• target investors, executives and researchers in the bio/pharma sector

• target healthcare professionals

• achieve rapid response

• select the option which meets your needs.

http://www.bioportfolio.com/advertis/advantag.htm 

Interested? Contact peter.barfoot@bioportfolio.com